Franklin Resources Inc Astrazeneca PLC Transaction History

Franklin Resources Inc

$346 Billion
Q3 2024

A detailed history of Franklin Resources Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Franklin Resources Inc holds 19,280,736 shares of AZN stock, worth $1.22 Billion. This represents 0.43% of its overall portfolio holdings.

Number of Shares

19,280,736

Previous 17,599,960 9.55%

Holding current value

$1.22 Billion

Previous $1.37 Billion 9.45%

% of portfolio

0.43%

Previous 0.44%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$76.67 - $87.62 $129 Million - $147 Million	1,680,776 Added 9.55%	19,280,736 $1.5 Billion
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $25.2 Million - $30.5 Million	377,844 Added 2.19%	17,599,960 $1.37 Billion
Q1 2024 May 13, 2024	BUY	$61.03 - $69.57 $453 Million - $516 Million	7,416,616 Added 75.64%	17,222,116 $1.17 Billion
Q4 2023 Feb 09, 2024	SELL	$61.89 - $69.28 $93.5 Million - $105 Million	-1,511,019 Reduced 13.35%	9,805,500 $660 Million
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $147,144 - $162,687	2,269 Added 0.02%	11,316,519 $766 Million
Q2 2023 Aug 11, 2023	SELL	$69.91 - $75.81 $39.7 Million - $43 Million	-567,395 Reduced 4.78%	11,314,250 $810 Million
Q1 2023 May 12, 2023	SELL	$63.15 - $71.6 $72.8 Million - $82.5 Million	-1,152,404 Reduced 8.84%	11,881,645 $825 Million
Q4 2022 Feb 10, 2023	SELL	$54.21 - $70.44 $203 Million - $263 Million	-3,735,738 Reduced 22.28%	13,034,049 $884 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $17.3 Million - $44.3 Million	-326,360 Reduced 1.91%	16,769,787 $920 Million
Q2 2022 Aug 11, 2022	BUY	$59.26 - $71.14 $102 Million - $122 Million	1,718,792 Added 11.18%	17,096,147 $1.13 Billion
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $294 Million - $354 Million	5,280,347 Added 52.3%	15,377,355 $1.02 Billion
Q4 2021 Feb 11, 2022	BUY	$54.02 - $63.83 $30.9 Million - $36.5 Million	572,432 Added 6.01%	10,097,008 $588 Million
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $198 Million - $216 Million	3,556,457 Added 59.59%	9,524,576 $572 Million
Q2 2021 Aug 13, 2021	SELL	$48.42 - $60.18 $10.4 Million - $12.9 Million	-213,780 Reduced 3.46%	5,968,119 $357 Million
Q1 2021 May 13, 2021	SELL	$47.16 - $54.44 $10 Million - $11.6 Million	-213,092 Reduced 3.33%	6,181,899 $307 Million
Q4 2020 Feb 10, 2021	BUY	$48.52 - $58.02 $13.1 Million - $15.6 Million	269,290 Added 4.4%	6,394,991 $320 Million
Q3 2020 Nov 12, 2020	SELL	$53.07 - $61.1 $11.1 Million - $12.8 Million	-209,529 Reduced 3.31%	6,125,701 $336 Million
Q2 2020 Aug 13, 2020	BUY	$43.1 - $55.31 $22.8 Million - $29.3 Million	529,731 Added 9.12%	6,335,230 $361 Million
Q1 2020 May 13, 2020	BUY	$37.79 - $51.33 $14.6 Million - $19.9 Million	387,659 Added 7.16%	5,805,499 $259 Million
Q4 2019 Feb 12, 2020	BUY	$42.46 - $50.46 $1.29 Million - $1.53 Million	30,382 Added 0.56%	5,417,840 $270 Million
Q3 2019 Nov 14, 2019	BUY	$40.12 - $45.47 $27.5 Million - $31.2 Million	685,908 Added 14.59%	5,387,458 $240 Million
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $2.96 Million - $3.31 Million	79,394 Added 1.72%	4,701,550 $194 Million
Q1 2019 May 14, 2019	BUY	$35.49 - $43.02 $2.7 Million - $3.27 Million	75,986 Added 1.67%	4,622,156 $187 Million
Q4 2018 Feb 12, 2019	BUY	$36.86 - $41.49 $36.4 Million - $41 Million	988,663 Added 27.79%	4,546,170 $173 Million
Q3 2018 Nov 13, 2018	BUY	$34.76 - $39.72 $70 Million - $80 Million	2,015,215 Added 130.66%	3,557,507 $141 Million
Q2 2018 Aug 14, 2018	BUY	$34.55 - $37.05 $19.1 Million - $20.5 Million	552,089 Added 55.76%	1,542,292 $54.2 Million
Q1 2018 May 10, 2018	SELL	$32.97 - $36.63 $18,595 - $20,659	-564 Reduced 0.06%	990,203 $34.6 Million
Q3 2017 Nov 13, 2017	BUY	$28.96 - $34.0 $28.7 Million - $33.7 Million	990,767	990,767 $33.6 Million

Others Institutions Holding AZN

# of Institutions

1,360

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $196B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Astrazeneca PLC Transaction History